IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Ambey Laboratories IPO offer price is ₹ 68.00 and got listed at ₹ 89.25. Read IPO details mentioned above.
Ambey Laboratories IPO listing price is ₹ 89.25, issue price is ₹ 68.00, and currently trading at ₹ 37.90 as on 5 march 2025. Infraprime Logistics IPO performance is show below with lates CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Ambey Laboratories IPO is a Book Building listing on NSE EMERGE exchange. The company is based in New Delhi and caters to Chemical - Pesticides sector. Fast Track Finsec is the merchant banker of Ambey Laboratories IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 2nd February 2024.
Ambey Laboratories IPO offer price is ₹ 68.00 and got listed at ₹ 89.25. Read Infraprime Logistics Technologies IPO details mentioned above.Ambey Laboratories IPO, based in New Delhi, operates in the Chemical - Pesticides sector with a focus on Manufactures agrochemical products for crop protection. The company is launching its SME IPO on the NSE EMERGE exchange, using the Book Building Issue method. Ambey Laboratories IPO size is ₹ 44.68 Cr. with fresh issue size of ₹ 42.55 Cr. and Offer for sale being 2.13.
The IPO allotment date for Ambey Laboratories IPO is expected to be 9th July 2024, after the finalization of basis of allotment. Investors can check Ambey Laboratories IPO allotment status on the registrars website, Link Intime India Private Limited. Ambey Laboratories IPO refund dates are 10th July 2024.
Ambey Laboratories IPO is expected to be listed on 11th July 2024.
The upper price band for the Ambey Laboratories IPO is set at ₹ 68.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Ambey Laboratories IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Ambey Laboratories IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 8th July 2024. After submission, funds are blocked until the basis of allotment of Ambey Laboratories IPO is finalised.
The merchant banker for Ambey Laboratories IPO is Fast Track Finsec Private Limited . Fast Track Finsec Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Ambey Laboratories IPO RHP for further details.
The registrar for Ambey Laboratories IPO is Link Intime India Private Limited. Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Ambey Laboratories IPO through their official website or helpline.
Ambey Laboratories IPO was subscribed 173.18 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Listing Gain
Issue Price vs Listing Price:Market Performance
Issue Price vs CMP:Ambey Laboratories IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Ambey Laboratories Financial Review Page
Merchant Banker(s) of Ambey Laboratories IPO: Fast Track Finsec Private Limited
Ambey Laboratories IPO subscription was 173.18 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Ambey Laboratories IPO listed at a listing price of 89.25 against the offer price of 68.00.
The current market price of Ambey Laboratories is 37.90.
Why Us?
